Results of a phase II multicenter trial of pentostatin and rituximab in patients with low-grade B-cell non-Hodgkin's lymphoma: An effective and minimally toxic regimen

Robert Drapkin, Nicholas J. Di Bella, David C. Faragher, Elizabeth Harden, Carmen Matei, William Hyman, Mae Mirabel, Kristi A. Boehm, Lina Asmar

Research output: Contribution to journal › Article › peer-review